nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemfibrozil—coronary artery disease—atherosclerosis	0.414	1	CtDrD
Gemfibrozil—PPARA—atherosclerosis	0.233	1	CbGaD
Gemfibrozil—SLCO1B1—Rosuvastatin—atherosclerosis	0.0276	0.113	CbGbCtD
Gemfibrozil—SLCO1B1—Ezetimibe—atherosclerosis	0.0276	0.113	CbGbCtD
Gemfibrozil—SLCO1B1—Simvastatin—atherosclerosis	0.0257	0.105	CbGbCtD
Gemfibrozil—SLCO1B1—Lovastatin—atherosclerosis	0.0251	0.103	CbGbCtD
Gemfibrozil—SLCO1B1—Pravastatin—atherosclerosis	0.0251	0.103	CbGbCtD
Gemfibrozil—CYP2C8—Simvastatin—atherosclerosis	0.0109	0.0445	CbGbCtD
Gemfibrozil—CYP2C8—Lovastatin—atherosclerosis	0.0106	0.0435	CbGbCtD
Gemfibrozil—CYP2C8—Pravastatin—atherosclerosis	0.0106	0.0435	CbGbCtD
Gemfibrozil—CYP2C19—Rosuvastatin—atherosclerosis	0.0098	0.0402	CbGbCtD
Gemfibrozil—CYP2C19—Simvastatin—atherosclerosis	0.00911	0.0373	CbGbCtD
Gemfibrozil—CYP2C19—Lovastatin—atherosclerosis	0.00891	0.0365	CbGbCtD
Gemfibrozil—CYP2C9—Rosuvastatin—atherosclerosis	0.00815	0.0334	CbGbCtD
Gemfibrozil—CYP2C9—Simvastatin—atherosclerosis	0.00757	0.031	CbGbCtD
Gemfibrozil—CYP2C9—Lovastatin—atherosclerosis	0.00741	0.0304	CbGbCtD
Gemfibrozil—CYP2C9—Pravastatin—atherosclerosis	0.00741	0.0304	CbGbCtD
Gemfibrozil—CYP3A4—Ezetimibe—atherosclerosis	0.00474	0.0194	CbGbCtD
Gemfibrozil—CYP3A4—Rosuvastatin—atherosclerosis	0.00474	0.0194	CbGbCtD
Gemfibrozil—CYP3A4—Simvastatin—atherosclerosis	0.0044	0.018	CbGbCtD
Gemfibrozil—CYP3A4—Pravastatin—atherosclerosis	0.00431	0.0177	CbGbCtD
Gemfibrozil—CYP3A4—Lovastatin—atherosclerosis	0.00431	0.0177	CbGbCtD
Gemfibrozil—Muscular weakness—Ezetimibe—atherosclerosis	0.000211	0.00284	CcSEcCtD
Gemfibrozil—Hepatobiliary disease—Rosuvastatin—atherosclerosis	0.00021	0.00283	CcSEcCtD
Gemfibrozil—Eosinophilia—Lovastatin—atherosclerosis	0.000209	0.00281	CcSEcCtD
Gemfibrozil—Disturbance in sexual arousal—Niacin—atherosclerosis	0.000208	0.0028	CcSEcCtD
Gemfibrozil—Pancreatitis—Lovastatin—atherosclerosis	0.000207	0.00279	CcSEcCtD
Gemfibrozil—Eosinophilia—Ezetimibe—atherosclerosis	0.000205	0.00276	CcSEcCtD
Gemfibrozil—Pancreatitis—Ezetimibe—atherosclerosis	0.000203	0.00273	CcSEcCtD
Gemfibrozil—Muscular weakness—Simvastatin—atherosclerosis	0.000202	0.00271	CcSEcCtD
Gemfibrozil—Rhinitis—Rosuvastatin—atherosclerosis	0.0002	0.00269	CcSEcCtD
Gemfibrozil—Eosinophilia—Simvastatin—atherosclerosis	0.000196	0.00263	CcSEcCtD
Gemfibrozil—Erectile dysfunction—Lovastatin—atherosclerosis	0.000194	0.00262	CcSEcCtD
Gemfibrozil—Liver function test abnormal—Niacin—atherosclerosis	0.000194	0.00261	CcSEcCtD
Gemfibrozil—Pancreatitis—Simvastatin—atherosclerosis	0.000194	0.00261	CcSEcCtD
Gemfibrozil—Photosensitivity reaction—Lovastatin—atherosclerosis	0.000193	0.00259	CcSEcCtD
Gemfibrozil—Erectile dysfunction—Ezetimibe—atherosclerosis	0.000191	0.00257	CcSEcCtD
Gemfibrozil—Liver function test abnormal—Pravastatin—atherosclerosis	0.000191	0.00257	CcSEcCtD
Gemfibrozil—Photosensitivity reaction—Ezetimibe—atherosclerosis	0.000189	0.00254	CcSEcCtD
Gemfibrozil—Muscular weakness—Niacin—atherosclerosis	0.000185	0.00249	CcSEcCtD
Gemfibrozil—Nasopharyngitis—Pravastatin—atherosclerosis	0.000185	0.00249	CcSEcCtD
Gemfibrozil—Neuropathy peripheral—Lovastatin—atherosclerosis	0.000185	0.00248	CcSEcCtD
Gemfibrozil—Urinary tract infection—Lovastatin—atherosclerosis	0.000183	0.00246	CcSEcCtD
Gemfibrozil—Muscular weakness—Pravastatin—atherosclerosis	0.000182	0.00245	CcSEcCtD
Gemfibrozil—Erectile dysfunction—Simvastatin—atherosclerosis	0.000182	0.00245	CcSEcCtD
Gemfibrozil—Neuropathy peripheral—Ezetimibe—atherosclerosis	0.000181	0.00244	CcSEcCtD
Gemfibrozil—Photosensitivity reaction—Simvastatin—atherosclerosis	0.00018	0.00243	CcSEcCtD
Gemfibrozil—Jaundice—Ezetimibe—atherosclerosis	0.00018	0.00242	CcSEcCtD
Gemfibrozil—Eosinophilia—Pravastatin—atherosclerosis	0.000177	0.00238	CcSEcCtD
Gemfibrozil—Depression—Simvastatin—atherosclerosis	0.000176	0.00236	CcSEcCtD
Gemfibrozil—Pancreatitis—Pravastatin—atherosclerosis	0.000175	0.00236	CcSEcCtD
Gemfibrozil—Mental disorder—Rosuvastatin—atherosclerosis	0.000175	0.00235	CcSEcCtD
Gemfibrozil—Hepatobiliary disease—Ezetimibe—atherosclerosis	0.000175	0.00235	CcSEcCtD
Gemfibrozil—Neuropathy peripheral—Simvastatin—atherosclerosis	0.000173	0.00232	CcSEcCtD
Gemfibrozil—Jaundice—Simvastatin—atherosclerosis	0.000172	0.00231	CcSEcCtD
Gemfibrozil—Flatulence—Rosuvastatin—atherosclerosis	0.000171	0.0023	CcSEcCtD
Gemfibrozil—Erectile dysfunction—Niacin—atherosclerosis	0.000167	0.00225	CcSEcCtD
Gemfibrozil—Erectile dysfunction—Pravastatin—atherosclerosis	0.000164	0.00221	CcSEcCtD
Gemfibrozil—Photosensitivity reaction—Pravastatin—atherosclerosis	0.000163	0.00219	CcSEcCtD
Gemfibrozil—Connective tissue disorder—Ezetimibe—atherosclerosis	0.000163	0.00219	CcSEcCtD
Gemfibrozil—Weight decreased—Pravastatin—atherosclerosis	0.000162	0.00217	CcSEcCtD
Gemfibrozil—Depression—Pravastatin—atherosclerosis	0.000159	0.00214	CcSEcCtD
Gemfibrozil—Angioedema—Rosuvastatin—atherosclerosis	0.000159	0.00213	CcSEcCtD
Gemfibrozil—Jaundice—Niacin—atherosclerosis	0.000158	0.00212	CcSEcCtD
Gemfibrozil—Neuropathy peripheral—Pravastatin—atherosclerosis	0.000156	0.0021	CcSEcCtD
Gemfibrozil—Jaundice—Pravastatin—atherosclerosis	0.000155	0.00209	CcSEcCtD
Gemfibrozil—Urinary tract infection—Pravastatin—atherosclerosis	0.000155	0.00208	CcSEcCtD
Gemfibrozil—Cough—Rosuvastatin—atherosclerosis	0.000151	0.00204	CcSEcCtD
Gemfibrozil—Mediastinal disorder—Ezetimibe—atherosclerosis	0.000149	0.00201	CcSEcCtD
Gemfibrozil—Alopecia—Lovastatin—atherosclerosis	0.000149	0.00201	CcSEcCtD
Gemfibrozil—Myalgia—Rosuvastatin—atherosclerosis	0.000148	0.00199	CcSEcCtD
Gemfibrozil—Arthralgia—Rosuvastatin—atherosclerosis	0.000148	0.00199	CcSEcCtD
Gemfibrozil—Alopecia—Ezetimibe—atherosclerosis	0.000146	0.00197	CcSEcCtD
Gemfibrozil—Rhinitis—Niacin—atherosclerosis	0.000145	0.00196	CcSEcCtD
Gemfibrozil—Mental disorder—Ezetimibe—atherosclerosis	0.000145	0.00195	CcSEcCtD
Gemfibrozil—Flatulence—Lovastatin—atherosclerosis	0.000145	0.00195	CcSEcCtD
Gemfibrozil—Hypoaesthesia—Niacin—atherosclerosis	0.000144	0.00194	CcSEcCtD
Gemfibrozil—Dysgeusia—Lovastatin—atherosclerosis	0.000144	0.00194	CcSEcCtD
Gemfibrozil—Rhinitis—Pravastatin—atherosclerosis	0.000143	0.00193	CcSEcCtD
Gemfibrozil—Confusional state—Rosuvastatin—atherosclerosis	0.000143	0.00192	CcSEcCtD
Gemfibrozil—Hypoaesthesia—Pravastatin—atherosclerosis	0.000142	0.00191	CcSEcCtD
Gemfibrozil—Flatulence—Ezetimibe—atherosclerosis	0.000142	0.00191	CcSEcCtD
Gemfibrozil—Alopecia—Simvastatin—atherosclerosis	0.00014	0.00188	CcSEcCtD
Gemfibrozil—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000139	0.00187	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000139	0.00187	CcSEcCtD
Gemfibrozil—Vision blurred—Lovastatin—atherosclerosis	0.000139	0.00187	CcSEcCtD
Gemfibrozil—Mental disorder—Simvastatin—atherosclerosis	0.000138	0.00186	CcSEcCtD
Gemfibrozil—Eye disorder—Niacin—atherosclerosis	0.000136	0.00183	CcSEcCtD
Gemfibrozil—Flatulence—Simvastatin—atherosclerosis	0.000136	0.00182	CcSEcCtD
Gemfibrozil—Dysgeusia—Simvastatin—atherosclerosis	0.000135	0.00181	CcSEcCtD
Gemfibrozil—Angioedema—Lovastatin—atherosclerosis	0.000134	0.00181	CcSEcCtD
Gemfibrozil—Anaemia—Ezetimibe—atherosclerosis	0.000133	0.00179	CcSEcCtD
Gemfibrozil—Vertigo—Lovastatin—atherosclerosis	0.000132	0.00178	CcSEcCtD
Gemfibrozil—Angioedema—Ezetimibe—atherosclerosis	0.000132	0.00177	CcSEcCtD
Gemfibrozil—Leukopenia—Lovastatin—atherosclerosis	0.000132	0.00177	CcSEcCtD
Gemfibrozil—Vision blurred—Simvastatin—atherosclerosis	0.00013	0.00174	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000129	0.00174	CcSEcCtD
Gemfibrozil—Alopecia—Niacin—atherosclerosis	0.000128	0.00173	CcSEcCtD
Gemfibrozil—Paraesthesia—Rosuvastatin—atherosclerosis	0.000127	0.00171	CcSEcCtD
Gemfibrozil—Anaemia—Simvastatin—atherosclerosis	0.000127	0.00171	CcSEcCtD
Gemfibrozil—Alopecia—Pravastatin—atherosclerosis	0.000126	0.0017	CcSEcCtD
Gemfibrozil—Cough—Ezetimibe—atherosclerosis	0.000126	0.00169	CcSEcCtD
Gemfibrozil—Angioedema—Simvastatin—atherosclerosis	0.000126	0.00169	CcSEcCtD
Gemfibrozil—Arthralgia—Lovastatin—atherosclerosis	0.000125	0.00169	CcSEcCtD
Gemfibrozil—Chest pain—Lovastatin—atherosclerosis	0.000125	0.00169	CcSEcCtD
Gemfibrozil—Myalgia—Lovastatin—atherosclerosis	0.000125	0.00169	CcSEcCtD
Gemfibrozil—Dyspepsia—Rosuvastatin—atherosclerosis	0.000125	0.00168	CcSEcCtD
Gemfibrozil—Flatulence—Niacin—atherosclerosis	0.000124	0.00168	CcSEcCtD
Gemfibrozil—Tension—Niacin—atherosclerosis	0.000124	0.00167	CcSEcCtD
Gemfibrozil—Vertigo—Simvastatin—atherosclerosis	0.000124	0.00166	CcSEcCtD
Gemfibrozil—Leukopenia—Simvastatin—atherosclerosis	0.000123	0.00166	CcSEcCtD
Gemfibrozil—Myalgia—Ezetimibe—atherosclerosis	0.000123	0.00165	CcSEcCtD
Gemfibrozil—Arthralgia—Ezetimibe—atherosclerosis	0.000123	0.00165	CcSEcCtD
Gemfibrozil—Chest pain—Ezetimibe—atherosclerosis	0.000123	0.00165	CcSEcCtD
Gemfibrozil—Nervousness—Niacin—atherosclerosis	0.000123	0.00165	CcSEcCtD
Gemfibrozil—Flatulence—Pravastatin—atherosclerosis	0.000123	0.00165	CcSEcCtD
Gemfibrozil—Tension—Pravastatin—atherosclerosis	0.000122	0.00164	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000122	0.00164	CcSEcCtD
Gemfibrozil—Dysgeusia—Pravastatin—atherosclerosis	0.000122	0.00164	CcSEcCtD
Gemfibrozil—Pain—Rosuvastatin—atherosclerosis	0.000121	0.00163	CcSEcCtD
Gemfibrozil—Constipation—Rosuvastatin—atherosclerosis	0.000121	0.00163	CcSEcCtD
Gemfibrozil—Confusional state—Lovastatin—atherosclerosis	0.000121	0.00163	CcSEcCtD
Gemfibrozil—Nervousness—Pravastatin—atherosclerosis	0.000121	0.00163	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Lovastatin—atherosclerosis	0.00012	0.00162	CcSEcCtD
Gemfibrozil—Vision blurred—Niacin—atherosclerosis	0.000119	0.0016	CcSEcCtD
Gemfibrozil—Confusional state—Ezetimibe—atherosclerosis	0.000119	0.0016	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000118	0.00158	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Lovastatin—atherosclerosis	0.000118	0.00158	CcSEcCtD
Gemfibrozil—Vision blurred—Pravastatin—atherosclerosis	0.000117	0.00158	CcSEcCtD
Gemfibrozil—Myalgia—Simvastatin—atherosclerosis	0.000117	0.00158	CcSEcCtD
Gemfibrozil—Arthralgia—Simvastatin—atherosclerosis	0.000117	0.00158	CcSEcCtD
Gemfibrozil—Chest pain—Simvastatin—atherosclerosis	0.000117	0.00158	CcSEcCtD
Gemfibrozil—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000117	0.00157	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000116	0.00156	CcSEcCtD
Gemfibrozil—Nervous system disorder—Ezetimibe—atherosclerosis	0.000115	0.00155	CcSEcCtD
Gemfibrozil—Angioedema—Niacin—atherosclerosis	0.000115	0.00155	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000115	0.00155	CcSEcCtD
Gemfibrozil—Anaemia—Pravastatin—atherosclerosis	0.000115	0.00155	CcSEcCtD
Gemfibrozil—Skin disorder—Ezetimibe—atherosclerosis	0.000114	0.00154	CcSEcCtD
Gemfibrozil—Angioedema—Pravastatin—atherosclerosis	0.000114	0.00153	CcSEcCtD
Gemfibrozil—Vertigo—Niacin—atherosclerosis	0.000114	0.00153	CcSEcCtD
Gemfibrozil—Syncope—Niacin—atherosclerosis	0.000113	0.00152	CcSEcCtD
Gemfibrozil—Confusional state—Simvastatin—atherosclerosis	0.000113	0.00152	CcSEcCtD
Gemfibrozil—Leukopenia—Niacin—atherosclerosis	0.000113	0.00152	CcSEcCtD
Gemfibrozil—Urticaria—Rosuvastatin—atherosclerosis	0.000113	0.00151	CcSEcCtD
Gemfibrozil—Oedema—Simvastatin—atherosclerosis	0.000112	0.00151	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Simvastatin—atherosclerosis	0.000112	0.00151	CcSEcCtD
Gemfibrozil—Abdominal pain—Rosuvastatin—atherosclerosis	0.000112	0.00151	CcSEcCtD
Gemfibrozil—Vertigo—Pravastatin—atherosclerosis	0.000112	0.0015	CcSEcCtD
Gemfibrozil—Leukopenia—Pravastatin—atherosclerosis	0.000111	0.0015	CcSEcCtD
Gemfibrozil—Loss of consciousness—Niacin—atherosclerosis	0.000111	0.00149	CcSEcCtD
Gemfibrozil—Cough—Niacin—atherosclerosis	0.00011	0.00148	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Simvastatin—atherosclerosis	0.00011	0.00148	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000109	0.00147	CcSEcCtD
Gemfibrozil—Cough—Pravastatin—atherosclerosis	0.000109	0.00146	CcSEcCtD
Gemfibrozil—Paraesthesia—Lovastatin—atherosclerosis	0.000108	0.00145	CcSEcCtD
Gemfibrozil—Myalgia—Niacin—atherosclerosis	0.000108	0.00145	CcSEcCtD
Gemfibrozil—Arthralgia—Niacin—atherosclerosis	0.000108	0.00145	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000107	0.00144	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000107	0.00144	CcSEcCtD
Gemfibrozil—Chest pain—Pravastatin—atherosclerosis	0.000106	0.00143	CcSEcCtD
Gemfibrozil—Arthralgia—Pravastatin—atherosclerosis	0.000106	0.00143	CcSEcCtD
Gemfibrozil—Myalgia—Pravastatin—atherosclerosis	0.000106	0.00143	CcSEcCtD
Gemfibrozil—Paraesthesia—Ezetimibe—atherosclerosis	0.000106	0.00142	CcSEcCtD
Gemfibrozil—Dyspepsia—Lovastatin—atherosclerosis	0.000106	0.00142	CcSEcCtD
Gemfibrozil—Dyspepsia—Ezetimibe—atherosclerosis	0.000104	0.00139	CcSEcCtD
Gemfibrozil—Fatigue—Lovastatin—atherosclerosis	0.000104	0.00139	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Niacin—atherosclerosis	0.000103	0.00139	CcSEcCtD
Gemfibrozil—Oedema—Niacin—atherosclerosis	0.000103	0.00139	CcSEcCtD
Gemfibrozil—Pain—Lovastatin—atherosclerosis	0.000103	0.00138	CcSEcCtD
Gemfibrozil—Constipation—Lovastatin—atherosclerosis	0.000103	0.00138	CcSEcCtD
Gemfibrozil—Confusional state—Pravastatin—atherosclerosis	0.000102	0.00138	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000102	0.00138	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000102	0.00137	CcSEcCtD
Gemfibrozil—Asthenia—Rosuvastatin—atherosclerosis	0.000102	0.00137	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Pravastatin—atherosclerosis	0.000102	0.00137	CcSEcCtD
Gemfibrozil—Oedema—Pravastatin—atherosclerosis	0.000102	0.00137	CcSEcCtD
Gemfibrozil—Fatigue—Ezetimibe—atherosclerosis	0.000102	0.00137	CcSEcCtD
Gemfibrozil—Shock—Niacin—atherosclerosis	0.000101	0.00137	CcSEcCtD
Gemfibrozil—Paraesthesia—Simvastatin—atherosclerosis	0.000101	0.00136	CcSEcCtD
Gemfibrozil—Constipation—Ezetimibe—atherosclerosis	0.000101	0.00135	CcSEcCtD
Gemfibrozil—Pain—Ezetimibe—atherosclerosis	0.000101	0.00135	CcSEcCtD
Gemfibrozil—Pruritus—Rosuvastatin—atherosclerosis	0.0001	0.00135	CcSEcCtD
Gemfibrozil—Skin disorder—Niacin—atherosclerosis	0.0001	0.00135	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Pravastatin—atherosclerosis	9.94e-05	0.00134	CcSEcCtD
Gemfibrozil—Feeling abnormal—Lovastatin—atherosclerosis	9.89e-05	0.00133	CcSEcCtD
Gemfibrozil—Dyspepsia—Simvastatin—atherosclerosis	9.88e-05	0.00133	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Lovastatin—atherosclerosis	9.82e-05	0.00132	CcSEcCtD
Gemfibrozil—Feeling abnormal—Ezetimibe—atherosclerosis	9.7e-05	0.00131	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Simvastatin—atherosclerosis	9.69e-05	0.0013	CcSEcCtD
Gemfibrozil—Diarrhoea—Rosuvastatin—atherosclerosis	9.69e-05	0.0013	CcSEcCtD
Gemfibrozil—Fatigue—Simvastatin—atherosclerosis	9.68e-05	0.0013	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Ezetimibe—atherosclerosis	9.63e-05	0.0013	CcSEcCtD
Gemfibrozil—Constipation—Simvastatin—atherosclerosis	9.6e-05	0.00129	CcSEcCtD
Gemfibrozil—Pain—Simvastatin—atherosclerosis	9.6e-05	0.00129	CcSEcCtD
Gemfibrozil—Urticaria—Lovastatin—atherosclerosis	9.54e-05	0.00128	CcSEcCtD
Gemfibrozil—Abdominal pain—Lovastatin—atherosclerosis	9.49e-05	0.00128	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Niacin—atherosclerosis	9.39e-05	0.00126	CcSEcCtD
Gemfibrozil—Dizziness—Rosuvastatin—atherosclerosis	9.37e-05	0.00126	CcSEcCtD
Gemfibrozil—Urticaria—Ezetimibe—atherosclerosis	9.35e-05	0.00126	CcSEcCtD
Gemfibrozil—Abdominal pain—Ezetimibe—atherosclerosis	9.31e-05	0.00125	CcSEcCtD
Gemfibrozil—Paraesthesia—Niacin—atherosclerosis	9.26e-05	0.00125	CcSEcCtD
Gemfibrozil—Feeling abnormal—Simvastatin—atherosclerosis	9.25e-05	0.00125	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Pravastatin—atherosclerosis	9.25e-05	0.00124	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Simvastatin—atherosclerosis	9.18e-05	0.00124	CcSEcCtD
Gemfibrozil—Somnolence—Niacin—atherosclerosis	9.17e-05	0.00123	CcSEcCtD
Gemfibrozil—Paraesthesia—Pravastatin—atherosclerosis	9.12e-05	0.00123	CcSEcCtD
Gemfibrozil—Dyspepsia—Niacin—atherosclerosis	9.08e-05	0.00122	CcSEcCtD
Gemfibrozil—Dyspepsia—Pravastatin—atherosclerosis	8.94e-05	0.0012	CcSEcCtD
Gemfibrozil—Rash—Rosuvastatin—atherosclerosis	8.93e-05	0.0012	CcSEcCtD
Gemfibrozil—Dermatitis—Rosuvastatin—atherosclerosis	8.92e-05	0.0012	CcSEcCtD
Gemfibrozil—Urticaria—Simvastatin—atherosclerosis	8.92e-05	0.0012	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Niacin—atherosclerosis	8.9e-05	0.0012	CcSEcCtD
Gemfibrozil—Abdominal pain—Simvastatin—atherosclerosis	8.88e-05	0.00119	CcSEcCtD
Gemfibrozil—Headache—Rosuvastatin—atherosclerosis	8.87e-05	0.00119	CcSEcCtD
Gemfibrozil—Pain—Niacin—atherosclerosis	8.82e-05	0.00119	CcSEcCtD
Gemfibrozil—Fatigue—Pravastatin—atherosclerosis	8.75e-05	0.00118	CcSEcCtD
Gemfibrozil—Constipation—Pravastatin—atherosclerosis	8.68e-05	0.00117	CcSEcCtD
Gemfibrozil—Pain—Pravastatin—atherosclerosis	8.68e-05	0.00117	CcSEcCtD
Gemfibrozil—Asthenia—Lovastatin—atherosclerosis	8.61e-05	0.00116	CcSEcCtD
Gemfibrozil—Pruritus—Lovastatin—atherosclerosis	8.49e-05	0.00114	CcSEcCtD
Gemfibrozil—Asthenia—Ezetimibe—atherosclerosis	8.45e-05	0.00114	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Niacin—atherosclerosis	8.43e-05	0.00113	CcSEcCtD
Gemfibrozil—Nausea—Rosuvastatin—atherosclerosis	8.41e-05	0.00113	CcSEcCtD
Gemfibrozil—Feeling abnormal—Pravastatin—atherosclerosis	8.37e-05	0.00113	CcSEcCtD
Gemfibrozil—Pruritus—Ezetimibe—atherosclerosis	8.33e-05	0.00112	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Pravastatin—atherosclerosis	8.3e-05	0.00112	CcSEcCtD
Gemfibrozil—Diarrhoea—Lovastatin—atherosclerosis	8.21e-05	0.00111	CcSEcCtD
Gemfibrozil—Urticaria—Niacin—atherosclerosis	8.19e-05	0.0011	CcSEcCtD
Gemfibrozil—Abdominal pain—Niacin—atherosclerosis	8.15e-05	0.0011	CcSEcCtD
Gemfibrozil—Urticaria—Pravastatin—atherosclerosis	8.07e-05	0.00109	CcSEcCtD
Gemfibrozil—Asthenia—Simvastatin—atherosclerosis	8.06e-05	0.00108	CcSEcCtD
Gemfibrozil—Diarrhoea—Ezetimibe—atherosclerosis	8.06e-05	0.00108	CcSEcCtD
Gemfibrozil—Abdominal pain—Pravastatin—atherosclerosis	8.03e-05	0.00108	CcSEcCtD
Gemfibrozil—Pruritus—Simvastatin—atherosclerosis	7.94e-05	0.00107	CcSEcCtD
Gemfibrozil—Dizziness—Lovastatin—atherosclerosis	7.94e-05	0.00107	CcSEcCtD
Gemfibrozil—Dizziness—Ezetimibe—atherosclerosis	7.79e-05	0.00105	CcSEcCtD
Gemfibrozil—Diarrhoea—Simvastatin—atherosclerosis	7.68e-05	0.00103	CcSEcCtD
Gemfibrozil—Vomiting—Lovastatin—atherosclerosis	7.63e-05	0.00103	CcSEcCtD
Gemfibrozil—Rash—Lovastatin—atherosclerosis	7.57e-05	0.00102	CcSEcCtD
Gemfibrozil—Dermatitis—Lovastatin—atherosclerosis	7.56e-05	0.00102	CcSEcCtD
Gemfibrozil—Headache—Lovastatin—atherosclerosis	7.52e-05	0.00101	CcSEcCtD
Gemfibrozil—Vomiting—Ezetimibe—atherosclerosis	7.49e-05	0.00101	CcSEcCtD
Gemfibrozil—Dizziness—Simvastatin—atherosclerosis	7.43e-05	0.000999	CcSEcCtD
Gemfibrozil—Rash—Ezetimibe—atherosclerosis	7.42e-05	0.000999	CcSEcCtD
Gemfibrozil—Dermatitis—Ezetimibe—atherosclerosis	7.42e-05	0.000998	CcSEcCtD
Gemfibrozil—Asthenia—Niacin—atherosclerosis	7.4e-05	0.000995	CcSEcCtD
Gemfibrozil—Headache—Ezetimibe—atherosclerosis	7.38e-05	0.000993	CcSEcCtD
Gemfibrozil—Pruritus—Niacin—atherosclerosis	7.29e-05	0.000982	CcSEcCtD
Gemfibrozil—Asthenia—Pravastatin—atherosclerosis	7.28e-05	0.00098	CcSEcCtD
Gemfibrozil—Pruritus—Pravastatin—atherosclerosis	7.18e-05	0.000967	CcSEcCtD
Gemfibrozil—Vomiting—Simvastatin—atherosclerosis	7.14e-05	0.000961	CcSEcCtD
Gemfibrozil—Nausea—Lovastatin—atherosclerosis	7.13e-05	0.00096	CcSEcCtD
Gemfibrozil—Rash—Simvastatin—atherosclerosis	7.08e-05	0.000953	CcSEcCtD
Gemfibrozil—Dermatitis—Simvastatin—atherosclerosis	7.07e-05	0.000952	CcSEcCtD
Gemfibrozil—Diarrhoea—Niacin—atherosclerosis	7.05e-05	0.000949	CcSEcCtD
Gemfibrozil—Headache—Simvastatin—atherosclerosis	7.03e-05	0.000947	CcSEcCtD
Gemfibrozil—Nausea—Ezetimibe—atherosclerosis	6.99e-05	0.000941	CcSEcCtD
Gemfibrozil—Diarrhoea—Pravastatin—atherosclerosis	6.95e-05	0.000935	CcSEcCtD
Gemfibrozil—Dizziness—Niacin—atherosclerosis	6.82e-05	0.000918	CcSEcCtD
Gemfibrozil—Dizziness—Pravastatin—atherosclerosis	6.71e-05	0.000903	CcSEcCtD
Gemfibrozil—Nausea—Simvastatin—atherosclerosis	6.67e-05	0.000898	CcSEcCtD
Gemfibrozil—Vomiting—Niacin—atherosclerosis	6.56e-05	0.000882	CcSEcCtD
Gemfibrozil—Rash—Niacin—atherosclerosis	6.5e-05	0.000875	CcSEcCtD
Gemfibrozil—Dermatitis—Niacin—atherosclerosis	6.5e-05	0.000874	CcSEcCtD
Gemfibrozil—Headache—Niacin—atherosclerosis	6.46e-05	0.000869	CcSEcCtD
Gemfibrozil—Vomiting—Pravastatin—atherosclerosis	6.45e-05	0.000869	CcSEcCtD
Gemfibrozil—Rash—Pravastatin—atherosclerosis	6.4e-05	0.000861	CcSEcCtD
Gemfibrozil—Dermatitis—Pravastatin—atherosclerosis	6.4e-05	0.000861	CcSEcCtD
Gemfibrozil—Headache—Pravastatin—atherosclerosis	6.36e-05	0.000856	CcSEcCtD
Gemfibrozil—Nausea—Niacin—atherosclerosis	6.12e-05	0.000824	CcSEcCtD
Gemfibrozil—Nausea—Pravastatin—atherosclerosis	6.03e-05	0.000811	CcSEcCtD
Gemfibrozil—SLCO1B1—Metabolism—HMOX1—atherosclerosis	5.49e-06	0.000159	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—ABCG1—atherosclerosis	5.46e-06	0.000158	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	5.43e-06	0.000158	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	5.38e-06	0.000156	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	5.37e-06	0.000156	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CYP27A1—atherosclerosis	5.36e-06	0.000155	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—LTA4H—atherosclerosis	5.33e-06	0.000155	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ABCG8—atherosclerosis	5.33e-06	0.000155	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—LPA—atherosclerosis	5.31e-06	0.000154	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—ALOX5—atherosclerosis	5.31e-06	0.000154	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	5.27e-06	0.000153	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—APOB—atherosclerosis	5.26e-06	0.000153	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—BGN—atherosclerosis	5.15e-06	0.000149	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	5.15e-06	0.000149	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—LCAT—atherosclerosis	5.14e-06	0.000149	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—FABP4—atherosclerosis	5.14e-06	0.000149	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—GSTM1—atherosclerosis	5.12e-06	0.000148	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—PTGS2—atherosclerosis	5.11e-06	0.000148	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	5.11e-06	0.000148	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—APOA5—atherosclerosis	5.09e-06	0.000148	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—APOA2—atherosclerosis	5.08e-06	0.000147	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PLA2G2A—atherosclerosis	5.08e-06	0.000147	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—ALOX5AP—atherosclerosis	5.08e-06	0.000147	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—ALOX15—atherosclerosis	5.08e-06	0.000147	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—APOA4—atherosclerosis	5.04e-06	0.000146	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—LPL—atherosclerosis	5.02e-06	0.000146	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—ABCG5—atherosclerosis	5.02e-06	0.000145	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	5.01e-06	0.000145	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CYP7A1—atherosclerosis	4.95e-06	0.000144	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	4.95e-06	0.000143	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PLA2G1B—atherosclerosis	4.9e-06	0.000142	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	4.9e-06	0.000142	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—GPX1—atherosclerosis	4.9e-06	0.000142	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—MAPK3—atherosclerosis	4.9e-06	0.000142	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	4.85e-06	0.000141	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—LPA—atherosclerosis	4.85e-06	0.00014	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	4.8e-06	0.000139	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	4.79e-06	0.000139	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—CD36—atherosclerosis	4.77e-06	0.000138	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—NAMPT—atherosclerosis	4.76e-06	0.000138	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—ALOX5—atherosclerosis	4.74e-06	0.000137	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	4.73e-06	0.000137	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—LIPC—atherosclerosis	4.73e-06	0.000137	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	4.72e-06	0.000137	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—APOC3—atherosclerosis	4.7e-06	0.000136	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—BGN—atherosclerosis	4.69e-06	0.000136	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—LDLR—atherosclerosis	4.67e-06	0.000135	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	4.66e-06	0.000135	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—APOA5—atherosclerosis	4.65e-06	0.000135	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CYP27A1—atherosclerosis	4.58e-06	0.000133	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CETP—atherosclerosis	4.56e-06	0.000132	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—MTHFR—atherosclerosis	4.52e-06	0.000131	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	4.51e-06	0.000131	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	4.51e-06	0.000131	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	4.47e-06	0.00013	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PPARA—atherosclerosis	4.44e-06	0.000129	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	4.42e-06	0.000128	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	4.4e-06	0.000128	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	4.38e-06	0.000127	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	4.38e-06	0.000127	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	4.37e-06	0.000127	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—SCARB1—atherosclerosis	4.37e-06	0.000127	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—ALOX15—atherosclerosis	4.34e-06	0.000126	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—APOA2—atherosclerosis	4.34e-06	0.000126	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—ALOX5AP—atherosclerosis	4.34e-06	0.000126	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PLA2G2A—atherosclerosis	4.34e-06	0.000126	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—ALOX5—atherosclerosis	4.32e-06	0.000125	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—AGT—atherosclerosis	4.3e-06	0.000125	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—ABCG5—atherosclerosis	4.29e-06	0.000124	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	4.28e-06	0.000124	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	4.25e-06	0.000123	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—NAMPT—atherosclerosis	4.25e-06	0.000123	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	4.22e-06	0.000122	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—LIPC—atherosclerosis	4.22e-06	0.000122	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ABCG1—atherosclerosis	4.22e-06	0.000122	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—APOE—atherosclerosis	4.21e-06	0.000122	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—APOC3—atherosclerosis	4.2e-06	0.000122	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—CAV1—atherosclerosis	4.17e-06	0.000121	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—LDLR—atherosclerosis	4.17e-06	0.000121	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—APOA1—atherosclerosis	4.16e-06	0.000121	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—LPA—atherosclerosis	4.14e-06	0.00012	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—HMGCR—atherosclerosis	4.13e-06	0.00012	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CETP—atherosclerosis	4.07e-06	0.000118	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—BGN—atherosclerosis	4.01e-06	0.000116	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	3.99e-06	0.000116	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	3.98e-06	0.000115	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—APOA5—atherosclerosis	3.97e-06	0.000115	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—FABP4—atherosclerosis	3.96e-06	0.000115	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—LCAT—atherosclerosis	3.96e-06	0.000115	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—SCARB1—atherosclerosis	3.9e-06	0.000113	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—APOA4—atherosclerosis	3.89e-06	0.000113	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—NAMPT—atherosclerosis	3.87e-06	0.000112	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	3.86e-06	0.000112	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	3.85e-06	0.000112	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—LIPC—atherosclerosis	3.85e-06	0.000112	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—APOC3—atherosclerosis	3.83e-06	0.000111	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CYP7A1—atherosclerosis	3.82e-06	0.000111	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PLA2G1B—atherosclerosis	3.82e-06	0.000111	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—LDLR—atherosclerosis	3.8e-06	0.00011	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PIK3CG—atherosclerosis	3.8e-06	0.00011	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	3.8e-06	0.00011	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	3.78e-06	0.00011	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	3.74e-06	0.000109	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	3.73e-06	0.000108	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	3.72e-06	0.000108	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CETP—atherosclerosis	3.71e-06	0.000108	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—ALOX5—atherosclerosis	3.69e-06	0.000107	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—HMGCR—atherosclerosis	3.68e-06	0.000107	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—ABCA1—atherosclerosis	3.68e-06	0.000107	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PPARG—atherosclerosis	3.67e-06	0.000106	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—INS—atherosclerosis	3.6e-06	0.000104	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—SCARB1—atherosclerosis	3.56e-06	0.000103	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CYP27A1—atherosclerosis	3.53e-06	0.000102	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	3.46e-06	0.0001	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	3.41e-06	9.89e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—HMGCR—atherosclerosis	3.36e-06	9.74e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	3.35e-06	9.71e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—APOA2—atherosclerosis	3.35e-06	9.71e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ALOX15—atherosclerosis	3.35e-06	9.71e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	3.35e-06	9.71e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	3.32e-06	9.63e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—NAMPT—atherosclerosis	3.31e-06	9.6e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ABCG5—atherosclerosis	3.31e-06	9.59e-05	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—AKT1—atherosclerosis	3.3e-06	9.58e-05	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—ALB—atherosclerosis	3.3e-06	9.56e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	3.29e-06	9.54e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—LIPC—atherosclerosis	3.29e-06	9.54e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—ABCA1—atherosclerosis	3.28e-06	9.52e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—APOC3—atherosclerosis	3.27e-06	9.48e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—LDLR—atherosclerosis	3.25e-06	9.42e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—LPA—atherosclerosis	3.2e-06	9.27e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CETP—atherosclerosis	3.17e-06	9.2e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—HMOX1—atherosclerosis	3.16e-06	9.15e-05	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—NOS3—atherosclerosis	3.15e-06	9.15e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—BGN—atherosclerosis	3.09e-06	8.97e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—APOA5—atherosclerosis	3.06e-06	8.88e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—SCARB1—atherosclerosis	3.04e-06	8.81e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	3.03e-06	8.78e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—APOB—atherosclerosis	3.02e-06	8.76e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—ABCA1—atherosclerosis	2.99e-06	8.68e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	2.96e-06	8.58e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	2.95e-06	8.55e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—GSTM1—atherosclerosis	2.94e-06	8.53e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—LPL—atherosclerosis	2.89e-06	8.37e-05	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PTGS2—atherosclerosis	2.88e-06	8.36e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—HMGCR—atherosclerosis	2.87e-06	8.32e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ALOX5—atherosclerosis	2.85e-06	8.26e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—HMOX1—atherosclerosis	2.82e-06	8.17e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—GPX1—atherosclerosis	2.82e-06	8.16e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CD36—atherosclerosis	2.74e-06	7.95e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—APOB—atherosclerosis	2.7e-06	7.82e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—GSTM1—atherosclerosis	2.62e-06	7.61e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—MTHFR—atherosclerosis	2.6e-06	7.53e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	2.59e-06	7.51e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—LPL—atherosclerosis	2.58e-06	7.47e-05	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—AKT1—atherosclerosis	2.57e-06	7.45e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—HMOX1—atherosclerosis	2.57e-06	7.45e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—ABCA1—atherosclerosis	2.56e-06	7.42e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—NAMPT—atherosclerosis	2.55e-06	7.41e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PPARA—atherosclerosis	2.55e-06	7.39e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—LIPC—atherosclerosis	2.54e-06	7.36e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—APOC3—atherosclerosis	2.52e-06	7.32e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—GPX1—atherosclerosis	2.51e-06	7.29e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—LDLR—atherosclerosis	2.51e-06	7.27e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—AGT—atherosclerosis	2.47e-06	7.16e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—APOB—atherosclerosis	2.46e-06	7.13e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CETP—atherosclerosis	2.45e-06	7.1e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CD36—atherosclerosis	2.45e-06	7.1e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—APOE—atherosclerosis	2.42e-06	7.01e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CAV1—atherosclerosis	2.4e-06	6.95e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—GSTM1—atherosclerosis	2.39e-06	6.94e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—APOA1—atherosclerosis	2.39e-06	6.93e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—LPL—atherosclerosis	2.35e-06	6.81e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—SCARB1—atherosclerosis	2.35e-06	6.8e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—MTHFR—atherosclerosis	2.32e-06	6.73e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—GPX1—atherosclerosis	2.29e-06	6.64e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PPARA—atherosclerosis	2.28e-06	6.6e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CD36—atherosclerosis	2.23e-06	6.47e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—HMGCR—atherosclerosis	2.21e-06	6.42e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—AGT—atherosclerosis	2.2e-06	6.39e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—HMOX1—atherosclerosis	2.19e-06	6.36e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PIK3CG—atherosclerosis	2.18e-06	6.33e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—APOE—atherosclerosis	2.16e-06	6.26e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CAV1—atherosclerosis	2.14e-06	6.2e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—APOA1—atherosclerosis	2.13e-06	6.19e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—MTHFR—atherosclerosis	2.11e-06	6.13e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PPARG—atherosclerosis	2.11e-06	6.11e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—APOB—atherosclerosis	2.1e-06	6.1e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PPARA—atherosclerosis	2.07e-06	6.02e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—INS—atherosclerosis	2.07e-06	5.99e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—GSTM1—atherosclerosis	2.04e-06	5.93e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—AGT—atherosclerosis	2.01e-06	5.83e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—LPL—atherosclerosis	2.01e-06	5.82e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ABCA1—atherosclerosis	1.97e-06	5.72e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—APOE—atherosclerosis	1.97e-06	5.71e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—GPX1—atherosclerosis	1.96e-06	5.68e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CAV1—atherosclerosis	1.95e-06	5.66e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PIK3CG—atherosclerosis	1.95e-06	5.65e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—APOA1—atherosclerosis	1.95e-06	5.64e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CD36—atherosclerosis	1.91e-06	5.53e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—ALB—atherosclerosis	1.89e-06	5.49e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PPARG—atherosclerosis	1.88e-06	5.45e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—INS—atherosclerosis	1.84e-06	5.35e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—NOS3—atherosclerosis	1.81e-06	5.26e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—MTHFR—atherosclerosis	1.81e-06	5.24e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PIK3CG—atherosclerosis	1.78e-06	5.15e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PPARA—atherosclerosis	1.77e-06	5.14e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—AGT—atherosclerosis	1.72e-06	4.98e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PPARG—atherosclerosis	1.71e-06	4.97e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—HMOX1—atherosclerosis	1.69e-06	4.91e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—ALB—atherosclerosis	1.69e-06	4.9e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—APOE—atherosclerosis	1.68e-06	4.88e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—INS—atherosclerosis	1.68e-06	4.88e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CAV1—atherosclerosis	1.67e-06	4.83e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—APOA1—atherosclerosis	1.66e-06	4.82e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PTGS2—atherosclerosis	1.66e-06	4.81e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—APOB—atherosclerosis	1.62e-06	4.7e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—NOS3—atherosclerosis	1.62e-06	4.69e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GSTM1—atherosclerosis	1.58e-06	4.58e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—LPL—atherosclerosis	1.55e-06	4.49e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—ALB—atherosclerosis	1.54e-06	4.47e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PIK3CG—atherosclerosis	1.52e-06	4.4e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GPX1—atherosclerosis	1.51e-06	4.38e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PTGS2—atherosclerosis	1.48e-06	4.29e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—NOS3—atherosclerosis	1.47e-06	4.28e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CD36—atherosclerosis	1.47e-06	4.27e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PPARG—atherosclerosis	1.47e-06	4.25e-05	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—AKT1—atherosclerosis	1.45e-06	4.2e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—INS—atherosclerosis	1.44e-06	4.17e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—MTHFR—atherosclerosis	1.39e-06	4.04e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PPARA—atherosclerosis	1.37e-06	3.97e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PTGS2—atherosclerosis	1.35e-06	3.91e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—AGT—atherosclerosis	1.33e-06	3.84e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—ALB—atherosclerosis	1.32e-06	3.82e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—APOE—atherosclerosis	1.3e-06	3.77e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CAV1—atherosclerosis	1.29e-06	3.73e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—APOA1—atherosclerosis	1.28e-06	3.72e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—NOS3—atherosclerosis	1.26e-06	3.65e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PIK3CG—atherosclerosis	1.17e-06	3.4e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PTGS2—atherosclerosis	1.15e-06	3.34e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PPARG—atherosclerosis	1.13e-06	3.28e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—INS—atherosclerosis	1.11e-06	3.22e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ALB—atherosclerosis	1.02e-06	2.95e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—NOS3—atherosclerosis	9.73e-07	2.82e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PTGS2—atherosclerosis	8.9e-07	2.58e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—AKT1—atherosclerosis	8.33e-07	2.42e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—AKT1—atherosclerosis	7.44e-07	2.16e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—AKT1—atherosclerosis	6.78e-07	1.97e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—AKT1—atherosclerosis	5.79e-07	1.68e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—AKT1—atherosclerosis	4.47e-07	1.3e-05	CbGpPWpGaD
